This easy-to-use, tandem reference tool includes information and guidelines in support of two distinct business processes: controlled substance ordering and electronic contract re-submittals.
The first of these supports compliance with the DEA’s final rule for electronic orders for controlled substances, allowing registrants to electronically order Schedule I and II substances, while also maintaining electronic records of these orders. This includes guidance on implementing the following suite of EDI transactions sets, replacing the need to use the manual paper-based Form 222 between purchaser and supplier: 850 Purchase Order, 855 Purchase Order Acknowledgment, 856 Ship Notice Manifest, 861 Receiving Advice/Acceptance Certificate.
Secondly, this publication provides guidance on the electronic re-submittal of chargebacks for errors in the contract administration process. This includes support for the implementation of the following EDI business transactions: 844 Product Transfer Account Adjustment, 849 Response to Product Transfer Account Adjustment. The guidelines are based on the 4040 version release of the X12 standards.